首页> 外文会议>2012 IEEE 5th International conference on management engineering amp; technology of statistics >The Estimation on the Innovation Performance of Manufacture of Medicines of China Based on the DEA-Benchmarking Model
【24h】

The Estimation on the Innovation Performance of Manufacture of Medicines of China Based on the DEA-Benchmarking Model

机译:基于DEA基准模型的中国医药制造业创新绩效评估。

获取原文
获取原文并翻译 | 示例

摘要

As an important high technology industry,Manufacture of medicines is developing fast and has a bright future.This paper presents an empirical analysis and a systemic evaluation on the manufacture of medicines innovation performance in China based on the provincial panel data of 2008 by using the DEA-Benchmarking model.Moreover,we try to show the feasibility and superiority for evaluating innovation performance using DEA-Benchmarking model based on the practical examples through comparing the results generated from different methods.
机译:作为重要的高新技术产业,医药制造业发展迅速,前景广阔。本文利用DEA方法,基于2008年省级面板数据,对我国医药制造业创新绩效进行实证分析和系统评价。 -基准模型。此外,我们通过比较不同方法产生的结果,以实际示例为基础,尝试展示使用DEA-基准模型评估创新绩效的可行性和优越性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号